Phio Pharmaceuticals Announces Publication in Frontiers in Immunology

          Phio Pharmaceuticals Announces Publication in Frontiers in ImmunologyJournal is the official publication of the International Union of Immunological SocietiesDecember 12, 2024 9:21 AM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - December 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more ...